C4 Therapeutics, Inc. (CCCC) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$104.99M | +0.3% |
| 2024 | -$105.32M | +20.5% |
| 2023 | -$132.49M | -3.4% |
| 2022 | -$128.18M | -52.8% |
| 2021 | -$83.89M | -26.5% |
| 2020 | -$66.33M | -94.5% |
| 2019 | -$34.10M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$104.99M | +0.3% |
| 2024 | -$105.32M | +20.5% |
| 2023 | -$132.49M | -3.4% |
| 2022 | -$128.18M | -52.8% |
| 2021 | -$83.89M | -26.5% |
| 2020 | -$66.33M | -94.5% |
| 2019 | -$34.10M | — |